Role of Hypertriglyceridemia in Patients With Stroke of Atherothrombotic Origin
A recent study in Neurology by Takao Hoshino and their team found that Hypertriglyceridemia is an important modifiable risk factor that drives residual vascular risk in patients with stroke of atherothrombotic origin, even while on statin therapy. Total of 870 patients, 217 (24.9%) had hypertriglyceridemia. High triglycerides levels were significantly associated with an increased prevalence of intracranial artery stenosis, particularly in the anterior circulation, rather than extracranial artery stenosis.
Patients with hypertriglyceridemia had a greater risk of major adverse cardiovascular in comparison to those without, even after adjustment for potential confounders, including baseline low-density lipoprotein cholesterol and statin use. The higher risk of vascular events in hypertriglyceridemia versus non- hypertriglyceridemia patients was observed among patients with stroke of atherothrombotic origin.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.